NEW DELHI, Feb 5 (Reuters) - Pfizer Inc (PFE.N) said on Friday it had withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India, after failing to meet the drug regulator's demand for a local safety and immunogenicity study. more...
